The possibility that GLP-1RAs could improve bone metabolism, which is essential for skeletal health, is of major interest and suggests that GLP-1 RAs could benefit the rising number of elderly T2DM patients with osteoporosis and high fracture risk. The gene discussed is GLP1R; the disease is osteoporosis.